Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    P1.01 - Early Detection and Screening - Biomarkers

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Early Detection and Screening - Biomarkers
    • +

      P1.01-01 - Comparison between Protein and Autoantibody Biomarkers for the Early Detection of Lung Cancer

      Presenter: Xiaoshuang Feng

      • Abstract

      Loading...

  • +

    P1.02 - Early Detection and Screening - Implementation

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Early Detection and Screening - Implementation
    • +

      P1.02-02 - Current Status, Challenges and Perspectives of Lung Cancer Screening in Low- and Middle-Income Countries

      Presenter: Milena Cavic

      • Abstract

      Loading...

    • +

      P1.02-03 - Budget Impact Analysis of Volume CT Lung Cancer Screening Based on NELSON Study Outcomes in Europe

      Presenter: Xuanqi Pan

      • Abstract

      Loading...

    • +

      P1.02-04 - Spatial Access to Lung Screening in British Columbia, Canada

      Presenter: Stephen Lam

      • Abstract

      Loading...

  • +

    P1.03 - Early Detection and Screening - Pulmonary Nodule

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Early Detection and Screening - Pulmonary Nodule
    • +

      P1.03-01 - Do We Follow Incidental Lung Nodules Appropriately? A Retrospective Study

      Presenter: Jasleen Kaur Pannu

      • Abstract

      Loading...

  • +

    P1.04 - Early Detection and Screening - Risk Stratification

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Early Detection and Screening - Risk Stratification
    • +

      P1.04-01 - Risk Stratification for Personalised Screening Intervals: Performance of PLCOm2012NoRace at Second Round of Manchester LHC

      Presenter: Patrick Bradley

      • Abstract

      Loading...

    • +

      P1.04-02 - Optimizing Screening Frequency and Interval Using a Deep Learning Algorithm

      Presenter: Stephen Lam

      • Abstract

      Loading...

    • +

      P1.04-03 - Independent Validation of the Maisonneuve Lung Cancer Risk Model to Optimize Screening Interval in High-risk Individuals

      Presenter: Giulia Veronesi

      • Abstract

      Loading...

  • +

    P1.05 - Early Stage Non-small Cell - Biomarkers

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Early Stage Non-small Cell - Biomarkers
    • +

      P1.05-01 - Phase II Study of ctDNA Directed Consolidation Durvalumab After Induction and Concurrent Durvalumab with SABR for Stage I NSCLC

      Presenter: Islam Mohamed

      • Abstract

      Loading...

    • +

      P1.05-02 - Mutations in CREBBP are Associated with Local Failure after Lung Stereotactic Body Radiation Therapy

      Presenter: Victor Chan Ng

      • Abstract

      Loading...

  • +

    P1.06 - Early Stage Non-small Cell - Systemic Therapy

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Early Stage Non-small Cell - Systemic Therapy
    • +

      P1.06-01 - Adjuvant Osimertinib vs Placebo in Completely Resected Stage IA2-IA3 EGFR-mutated NSCLC: The ADAURA2 Phase III Study

      Presenter: Toon Van der Gronde

      • Abstract

      Loading...

  • +

    P1.07 - Epidemiology

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Epidemiology
    • +

      P1.07-01 - Early Detection Plus Timely Surgery Remains the Standard despite Advances in Immunotherapy

      Presenter: Emanuela Taioli

      • Abstract

      Loading...

    • +

      P1.07-02 - Personal and Family HiStory of CANcer in Patients with Non-small Cell Lung Cancer: Preliminary Data of the SCAN Study

      Presenter: Juan Carlos Laguna

      • Abstract

      Loading...

  • +

    P1.08 - Global Health, Health Services Research, and Health Economics - Cost issues

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Global Health, Health Services Research, and Health Economics - Cost issues
    • +

      P1.08-01 - Updated Costs and Survival Expectations for Stage IV Lung Cancer in Australia

      Presenter: Preston Ngo

      • Abstract

      Loading...

  • +

    P1.09 - Global Health, Health Services Research, and Health Economics - Support to Patients and Staff

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Global Health, Health Services Research, and Health Economics - Support to Patients and Staff
    • +

      P1.09-01 - The Lung Cancer Patient Experience and Care Pathway: A Multi-Country Survey

      Presenter: Pauline Frank

      • Abstract

      Loading...

    • +

      P1.09-02 - Real-world Clinical Characteristics and Treatment Patterns of METExon 14 Skipping Mutation in Advanced/Metastatic NSCLC

      Presenter: Xiuning Le

      • Abstract

      Loading...

    • +

      P1.09-03 - Multidisciplinary Thoracic Tumors Board Survey in Spain

      Presenter: Bartomeu Massutí

      • Abstract

      Loading...

  • +

    P1.10 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
    • +

      P1.10-01 - Phase 3 Study of Durvalumab Combined with Oleclumab or Monalizumab in Patients with Unresectable Stage III NSCLC (PACIFIC-9)

      Presenter: Aarthi Gopinathan

      • Abstract

      Loading...

    • +

      P1.10-02 - ImmunoPET: A Phase 0/1 Study Characterising PD-L1 with 89Zr-Durvalumab (MEDI4736) PET/CT in Stage III NSCLC Patients Receiving Chemoradiation

      Presenter: Fiona Hegi-Johnson

      • Abstract

      Loading...

    • +

      P1.10-03 - A Deep Learning Auto-Segmentation Tool for Cardiac Substructures in 4D Radiotherapy Planning for Locally Advanced Lung Cancer

      Presenter: Gerard M Walls

      • Abstract

      Loading...

    • +

      P1.10-04 - Impact of Radiation Dose to the Immune Cells in Unresectable or Stage III Non-Small Cell Lung Cancer in the Durvalumab Era

      Presenter: Neal Sean Mccall

      • Abstract

      Loading...